BREAKING: Market Extends Rally Ahead Of Fed Decision
Murphy USA (MUSA) stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an increase from 90 to 93.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. This proprietary rating measures technical performance by showing how a stock’s price action over the last 52 weeks measures up against that of the other stocks in our database.
Over 100 years of market history reveals that the market’s biggest winners tend to have an RS Rating north of 80 at the beginning of a new climb.
See How IBD Helps You Make More Money In Stocks
Murphy USA stock is building a consolidation with a 202.30 buy point. See if it can clear the breakout price in heavy trade. Read “Looking For The Next Big Stock Market Winners? Start With These 3 Steps” for more tips.
The gas and convenient store operator saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 75% to 96%. Revenue rose from 62% to 67%.
Murphy USA stock earns the No. 1 rank among its peers in the Retail-Super/Mini Markets industry group. Murphy USA (MUSA) and National Grocers Vitamin Cottage (NGVC) are also among the group’s highest-rated stocks.
Get these newsletters delivered to your inbox & more info about our products & services. Privacy Policy & Terms of Use
YOU MIGHT ALSO LIKE:
MarketSmith’s Tools Can Help The Individual Investor
IBD Live: A New Tool For Daily Stock Market Analysis
Profit From Short-Term Trends With SwingTrader
How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks
3/03/2022 Grocery-store operator Kroger broke out on strong earnings and bullish guidance, despite inflation and labor concerns.
3/03/2022 Grocery-store operator Kroger broke out on strong earnings and bullish…
Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20!
Get market updates, educational videos, webinars, and stock analysis.
Learn how you can make more money with IBD’s investing tools, top-performing stock lists, and educational content.
Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. Authors may own the stocks they discuss. The information and content are subject to change without notice.
*Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade prices are not sourced from all markets.
Ownership data provided by Refinitiv and Estimates data provided by FactSet.
© 2000-2022 Investor’s Business Daily, LLC. All rights reserved
